Sahoo, Arpita published the artcileA comprehensive review on Siragata vata w.s.r to Raynaud’s disease, Application In Synthesis of 21829-25-4, the main research area is review nifedipine prazocin glycerin trinitrate Siragata Vata Raynaud disease.
Siragata Vata is an Ekanga (localized) Vatavyadhi described by Maharshis. It is better correlated with Raynaud’s disease in modern medical science. Vasospasm or obstruction of blood vessels results cessation of blood flow to the fingers, hand, lips, nose and toes make worse the condition. Shita Ahara Vihar, Chinta, Shoka, Srota Avarodha are causative factors. Pallor or blanching, dusky cyanosis and painful red engorgement are common symptoms. Modern medicines like nifedipine, prazocin, glycerin trinitrate are advised for treatment of Raynaud’s disease but these medicines may affect other organs functions and produce side effects. Ayurvedic therapies described for Siragata Vata can be beneficial for the treatment of Raynaud’s disease without any alteration of other organs functions. Leech therapy has vasodilator effect which can improve the vasospasm. In this review paper detail comparison between Siragata Vata and Raynaud’s disease has been described.
World Journal of Pharmacy and Pharmaceutical Sciences published new progress about Raynaud disease. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Application In Synthesis of 21829-25-4.